Transhuman Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1

- Investments
-
20
- Portfolio
-
12
- Exits
-
4

Transhuman Capital General Information
Company Description
Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan. The firm seeks to invest in the therapeutics, biotechnology, medical devices, and healthcare technologies sectors.
Business Details
Website
transhumancapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Ann Arbor, MI
- United States
Transhuman Capital Investments (20)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Retension Pharmaceutical | 21-Aug-2024 | Early Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
Response Pharmaceuticals | 28-Jun-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Kriya Therapeutics | 26-Jul-2023 | Drug Discovery | Generating Revenue | |||
Bond Biosciences | 25-Jan-2022 | Drug Discovery | Clinical Trials - General | |||
EVOQ Therapeutics | 25-Oct-2021 | Biotechnology | Startup | |||
Eight Sleep | 30-Aug-2021 | Electronics (B2C) | Generating Revenue | |||
Asalyxa Bio | 26-Jul-2021 | Drug Delivery | Out of Business | |||
Kriya Therapeutics | 14-Jul-2021 | Drug Discovery | Generating Revenue | |||
Dvant Pharmaceuticals | 19-Mar-2021 | Seed Round | Drug Discovery | Stealth | ||
Silicon Therapeutics | 26-Feb-2021 | Buyout/LBO | Drug Discovery | Clinical Trials - Phase 1 |
Transhuman Capital Exits (4)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Asalyxa Bio | 05-Jul-2024 | Out of Business | |
Roivant Sciences | 30-Sep-2021 | ||
Sio Gene Therapies | 11-Jun-2015 | IPO | |
Marinus Pharmaceuticals | 31-Jul-2014 | IPO |
Transhuman Capital Investments by Industry, Year, and Region
Transhuman Capital Co-Investors (88)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Biosciences Research and Commercialization Center | 2 |
![]() |
![]() |
||
Evolution VC Partners |
![]() |
![]() |
|||
Michigan Rise |
![]() |
![]() |
|||
General Catalyst |
![]() |
![]() |
|||
Valor Equity Partners |
![]() |
![]() |
Transhuman Capital FAQs
-
What is Transhuman Capital?
Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan.
-
When was Transhuman Capital founded?
Transhuman Capital was founded in 2014.
-
Where is Transhuman Capital headquartered?
Transhuman Capital is headquartered in Ann Arbor, MI.
-
How many investments has Transhuman Capital made?
Transhuman Capital has made 20 investments.
-
What has Transhuman Capital invested in?
Transhuman Capital has made numerous investments in companies like Retension Pharmaceutical, Response Pharmaceuticals, and Kriya Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has Transhuman Capital invested in recently?
Transhuman Capital's latest investment was on 21-Aug-2024 in Retension Pharmaceutical, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »